rosiglitazone
-
Effect of PPAR-γ Agonist Rosiglitazone on Bone Mineral Density and Serum Adipokines in C57BL/6 Male Mice
Petr Dan Broulík, L. Šefc, M. Haluzík
2011, Vol. 57, Issue 4, pp. 133-138 -
Rosiglitazone Improves Insulin Resistance, Lipid Profile and Promotes Adiposity in a Genetic Model of Metabolic Syndrome X
O. Šeda, L. Kazdová, D. Křenová, Vladimír Křen
2002, Vol. 48, Issue 6, pp. 237-241
